Oncotest offer Reinnervate’s 3D cell technology to clients
Oncology CRO, Oncotest GmbH, will incorporate a new 3D cell culture technology into its range of preclinical assay services.
Archives for January 8, 2013
Lonza to double ADC capacity to address Visp challenge
Lonza plans to double ADC capacity at its facility in Visp, Switzerland by 2014 in a move that it says could create new jobs.